IPNews® – Pfizer Inc. and Northwestern University filed a lawsuit on Friday in an attempt to prevent a generic-drug manufacturer from producing a form of the patented drug Lyrica.
The company and the university have actively fought to protect the patent for the drug, which brought in more than $3.7 billion in revenues in 2011.